Muscarinic receptors play a major role in gallbladder function, although the muscarinic receptor(s) mediating smooth muscle contractility is unclear. This study compared smooth muscle contractile responses to carbamylcholine (10 Ϫ7 -10 Ϫ3 M) in isolated gallbladder from wild-type and M 2 , M 3 , and M 4 receptor knockout mice. Carbamylcholine-induced contraction in gallbladder was associated with tachyphylaxis and the release of a cyclooxygenase product because indomethacin (10 Ϫ6 M) inhibited carbamylcholine-induced contraction. The M 3 receptor was the major muscarinic receptor involved in contraction because carbamylcholine-induced contractility was inhibited in gallbladder from M 3 receptor knockout mice. Furthermore, the muscarinic receptor antagonists 11]benzodiazepine-6-one (AF-DX 116) and pirenzepine dextrally shifted contraction to carbamylcholine in gallbladder from wild-type, M 2 , and M 4 receptor knockout mice, with affinities consistent with M 3 receptor interaction. In addition, maximal contraction to carbamylcholine was reduced in gallbladder from M 2 receptor knockout mice and affinities for AF-DX 116 and pirenzepine in gallbladder from M 3 receptor knockout mice were consistent with their affinities at M 2 receptors. In M 4 receptor knockout mice, contraction to carbamylcholine was dextrally shifted, although the affinities for AF-DX 116 and pirenzepine in gallbladder from M 2 or M 3 knockout mice were not similar to their affinities at M 4 receptors. The M 4 receptor may serve as an accessory protein necessary for optimal potency of M 2 and M 3 receptor-mediated responses. Thus, muscarinic receptor knockout mice provided direct and unambiguous evidence that M 3 , and to a lesser extent, M 2 receptors are the predominant muscarinic receptors mediating gallbladder contractility, and M 4 receptors appear necessary for optimal potency of carbamylcholine in gallbladder contraction.